- Substantial growth once again reported by Industrial Metrology and Medical Technology business groups
- Earnings impacted by continued high level of future-oriented expenditure and decline in business in the Semiconductor Manufacturing Technology business group
- Consistent continuation of investment strategy
- ZEISS continues to increase expenditure on research and development
The company put in a good performance in some sectors despite a partly difficult economic environment and generated revenue totaling EUR 4.190 billion (prior year: EUR 4.163 billion) and earnings (EBIT) of EUR 335 million (prior year: EUR 420 million).
In fiscal year 2012/13 different developments were observed in the market segments relevant to ZEISS. Overall, the market situation was tense: while slight growth was reported in the market for medical technology, the markets for microscopy, industrial metrology and eyeglass lenses remained stable. Demand in the market for lithography systems continued to decline in the first half of the fiscal year compared to the previous year, but picked up again in the second half. "In fiscal year 2012/13 we reached and partly exceeded our targets. ZEISS put in a good performance despite the challenging business environment and the weakness of the economy at the beginning of the year," said Dr. Michael Kaschke, President and CEO of Carl Zeiss AG. "We made no compromises in our multi-year investment program – the biggest ever in the company's history – but continued to implement it consistently and systematically.“
____________________________________